医学
肿瘤科
累积发病率
内科学
入射(几何)
回顾性队列研究
生物标志物
基因表达谱
年轻人
危险分层
表达式(计算机科学)
生存分析
比例危险模型
累积风险
风险评估
作者
Lijun Hao,Teng Xu,Yuanyuan Yu,Qin Miao Huang,Li An,Yanjie Cui
摘要
OBJECTIVES: This study aims to investigate the predictive value of S1PR3 for the 3-year cumulative incidence of relapse (CIR) in adult patients with B-cell acute lymphoblastic leukemia (B-ALL). METHODS: This retrospective study enrolled 285 adult patients with B-ALL and 13 healthy controls from January 2019 through January 2022. S1PR3 expression was analyzed in leukemia cell lines and peripheral blood mononuclear cells (MCs) using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot. S1PR3 expression in bone marrow MCs was also measured by RT-qPCR. Predictive value was assessed using receiver operating characteristic curve analysis. Spearman correlation analysis was performed for correlation studies. Kaplan-Meier curves were employed for survival analysis. Cox regression was conducted for risk factor analysis. RESULTS: S1PR3 was upregulated in leukemia cell lines and B-ALL patient MCs compared with controls (P < .001). Relapsed patients demonstrated elevated S1PR3 levels compared with nonrelapsed patients (P < .001). S1PR3 expression predicted B-ALL relapse with an area under the curve of 0.887. Patients with high S1PR3 had a significantly higher relapse rate than those with low S1PR3 (P < .001). S1PR3 expression was closely associated with clinicopathologic characteristics. High S1PR3 expression was associated with a leftward shift in Kaplan-Meier curves and significantly increased CIR in patients (P < .001). High S1PR3 expression was an independent risk factor for relapse within 3 years in patients with B-ALL (P < .05). CONCLUSIONS: Elevated S1PR3 expression is an independent predictor of relapse in adult B-ALL, providing a novel biomarker to enhance risk stratification and guide potential targeted interventions.
科研通智能强力驱动
Strongly Powered by AbleSci AI